<VariationArchive VariationID="14741" VariationName="NM_000213.5(ITGB4):c.4574_4575del (p.Ala1525fs)" VariationType="Deletion" Accession="VCV000014741" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2022-04-02" MostRecentSubmission="2022-04-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29780" VariationID="14741">
      <GeneList>
        <Gene Symbol="GALK1" FullName="galactokinase 1" GeneID="2584" HGNC_ID="HGNC:4118" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="75751469" stop="75765192" display_start="75751469" display_stop="75765192" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="73754017" stop="73761279" display_start="73754017" display_stop="73761279" Strand="-" />
          </Location>
          <OMIM>604313</OMIM>
        </Gene>
        <Gene Symbol="ITGB4" FullName="integrin subunit beta 4" GeneID="3691" HGNC_ID="HGNC:6158" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="75721459" stop="75757818" display_start="75721459" display_stop="75757818" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="73717515" stop="73753898" display_start="73717515" display_stop="73753898" Strand="+" />
          </Location>
          <OMIM>147557</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000213.5(ITGB4):c.4574_4575del (p.Ala1525fs)</Name>
      <CanonicalSPDI>NC_000017.11:75755715:CT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="75755716" stop="75755717" display_start="75755716" display_stop="75755717" variantLength="2" positionVCF="75755715" referenceAlleleVCF="GCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="73751797" stop="73751798" display_start="73751797" display_stop="73751798" variantLength="2" positionVCF="73751796" referenceAlleleVCF="GCT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A1455fs</ProteinChange>
      <ProteinChange>A1508fs</ProteinChange>
      <ProteinChange>A1525fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.73751797_73751798del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.73751797_73751798del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.75755716_75755717del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.75755716_75755717del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007372.2" sequenceAccession="NG_007372" sequenceVersion="2" change="g.39259_39260del">
            <Expression>NG_007372.2:g.39259_39260del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008079.2" sequenceAccession="NG_008079" sequenceVersion="2" change="g.14483_14484del">
            <Expression>NG_008079.2:g.14483_14484del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000213.5" sequenceAccession="NM_000213" sequenceVersion="5" change="c.4574_4575del" MANESelect="true">
            <Expression>NM_000213.5:c.4574_4575del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000204.3" sequenceAccession="NP_000204" sequenceVersion="3" change="p.Ala1525fs">
            <Expression>NP_000204.3:p.Ala1525fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001005619.1" sequenceAccession="NM_001005619" sequenceVersion="1" change="c.4523_4524del">
            <Expression>NM_001005619.1:c.4523_4524del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001005619.1" sequenceAccession="NP_001005619" sequenceVersion="1" change="p.Ala1508fs">
            <Expression>NP_001005619.1:p.Ala1508fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001005731.3" sequenceAccession="NM_001005731" sequenceVersion="3" change="c.4364_4365del">
            <Expression>NM_001005731.3:c.4364_4365del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001005731.1" sequenceAccession="NP_001005731" sequenceVersion="1" change="p.Ala1455fs">
            <Expression>NP_001005731.1:p.Ala1455fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321123.2" sequenceAccession="NM_001321123" sequenceVersion="2" change="c.4364_4365del">
            <Expression>NM_001321123.2:c.4364_4365del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308052.1" sequenceAccession="NP_001308052" sequenceVersion="1" change="p.Ala1455fs">
            <Expression>NP_001308052.1:p.Ala1455fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001381985.1" sequenceAccession="NM_001381985" sequenceVersion="1" change="c.*22+2317_*22+2318del">
            <Expression>NM_001381985.1:c.*22+2317_*22+2318del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1430" sequenceAccession="LRG_1430">
            <Expression>LRG_1430:g.14483_14484del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="147557.0013" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 147557.0013 from the sequence reported in Figure 7 of the paper by Jonkman et al., 2002 (PubMed 12485428).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000213.5(ITGB4):c.4574_4575del (p.Ala1525fs) AND Epidermolysis bullosa, junctional 5A, intermediate" Accession="RCV002051630" Version="9">
        <ClassifiedConditionList TraitSetID="73929">
          <ClassifiedCondition DB="MedGen" ID="C5676956">Epidermolysis bullosa, junctional 5A, intermediate</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2002-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-04-02" MostRecentSubmission="2022-04-02">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12485428</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9546354</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9892956</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="73929" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="62006" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, GENERALIZED INTERMEDIATE</ElementValue>
                <XRef Type="MIM" ID="619816" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, NON-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="619816" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa, junctional 5A, intermediate</ElementValue>
                <XRef ID="MONDO:0030768" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">JEB5A</ElementValue>
                <XRef Type="MIM" ID="619816" DB="OMIM" />
              </Symbol>
              <XRef ID="C5676956" DB="MedGen" />
              <XRef ID="MONDO:0030768" DB="MONDO" />
              <XRef Type="MIM" ID="619816" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="36129" SubmissionDate="2022-03-29" DateLastUpdated="2022-04-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="147557.0013_EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, INTERMEDIATE" title="ITGB4, 2-BP DEL, 4733CT_EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, INTERMEDIATE" />
        <ClinVarAccession Accession="SCV000036129" DateUpdated="2022-04-02" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Jonkman et al. (2002) reported a patient with predominant features of epidermolysis bullosa simplex confined to the hands and feet (JEB5A; 619816) due to a heterozygous 2-bp deletion (4733delCT) in the ITGB4 gene, resulting in in-frame skipping of exon 36 and a deduced 50-amino acid deletion (1450-1499) within the third fibronectin type III repeat in the cytoplasmic domain of integrin beta-4. Although mutation in exon 36 of the ITGB4 gene had been reported in epidermolysis bullosa with pyloric atresia (226730) (see 147557.0007), this patient had no history of pyloric atresia. The patient, a 49-year-old female, had mild blistering of hands and feet from birth, dystrophy of the nails with onychogryposis, and enamel hypoplasia. Electron microscopy and antigen mapping of a skin blister revealed that the level of separation was intraepidermal, low in the basal keratinocytes through the attachment plaque of the hemidesmosome. Immunofluorescence microscopy revealed absent binding of monoclonal antibody 450-11 A against the third fibronectin III repeat on the intracellular domain of integrin beta-4, whereas binding was reduced with monoclonal antibodies recognizing epitopes on amino-terminal and carboxy-terminal ends of the polypeptide. Immunoblot analysis demonstrated a 5-kD shorter beta-4 polypeptide. The patient was also expected to be heterozygous for a null allele, as no full-size protein was detected in vitro and the epitope 450-11 A was absent in vivo. These data showed that deletion of the third fibronectin type III repeat in the cytoplasmic domain of integrin beta-4, which is thought to interact with BP180/type XVII collagen (113811), is clinically pathogenic and results in a mild phenotype. Although Jonkman et al. (2002) stated that the level of skin separation was intraepidermal (i.e., consistent with that seen in epidermolysis bullosa simplex), they pointed out that 'pseudojunctional' splits very low in the basal cells had been reported in patients with JEB with pyloric atresia carrying mutations in the ITGB4 gene (e.g., Pulkkinen et al. (1998), Mellerio et al. (1998)).</Attribute>
              <Citation>
                <ID Source="PubMed">12485428</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9546354</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9892956</ID>
              </Citation>
              <XRef DB="OMIM" ID="619816" Type="MIM" />
              <XRef DB="OMIM" ID="226730" Type="MIM" />
              <XRef DB="OMIM" ID="113811" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGB4" />
          </GeneList>
          <Name>ITGB4, 2-BP DEL, 4733CT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 4733CT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="147557.0013" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, INTERMEDIATE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="36129" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, INTERMEDIATE" MappingRef="Preferred">
        <MedGen CUI="C5676956" Name="Epidermolysis bullosa, junctional 5A, intermediate" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

